Keyphrases
Clinical Trials
100%
Multiple Sclerosis
100%
Patient-reported Outcomes
100%
Patient-Reported Outcomes Measurement Information System (PROMIS)
33%
Patient-reported Outcome Assessment
33%
Clinical Research
16%
Health-related Quality of Life
16%
Patient-centered Research
16%
Health Status
16%
Multiple Sclerosis Treatment
16%
National Institutes of Health
16%
Comparative Effectiveness
16%
Disease-modifying Therapy
16%
Measurement System
16%
Neuro-QoL
16%
Standardized Approach
16%
Multiple Sclerosis Care
16%
Preference-based
16%
Daclizumab
16%
Teriflunomide
16%
Medicine and Dentistry
Patient-Reported Outcome
100%
Multiple Sclerosis Clinical Trial
100%
Multiple Sclerosis
60%
Outcome Assessment
30%
Health Status
10%
Disease Modifying Therapy
10%
Daclizumab
10%
Teriflunomide
10%
Clinical Research
10%
Clinical Trial
10%
Quality of Life
10%
Nursing and Health Professions
Patient-Reported Outcome
100%
Multiple Sclerosis
100%
Outcome Assessment
30%
Quality of Life
10%
National Health Organization
10%
Food and Drug Administration
10%
Health Status
10%
Teriflunomide
10%
Daclizumab
10%
Diseases
10%
Information Systems
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Multiple Sclerosis
100%
Clinical Research
12%
Health Status
12%
Teriflunomide
12%
Daclizumab
12%
Diseases
12%
Neuroscience
Multiple Sclerosis
100%
Multiple Sclerosis Clinical Trial
100%
Teriflunomide
16%
Daclizumab
16%